Hospital General Universitario de Elche -ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2022

  1. Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial

    Thrombosis and haemostasis, Vol. 122, Núm. 10, pp. 1653-1661

  2. SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients (2021)

    Clinical and Translational Oncology, Vol. 24, Núm. 4, pp. 724-732

2021

  1. Rationale, design and methodology of TESEO study: a registry of thrombosis and neoplasia of SEOM (Spanish Society of Medical Oncology)

    Clinical and Translational Oncology, Vol. 23, Núm. 4, pp. 799-811

2020

  1. A snapshot of cancer-associated thromboembolic disease in 2018–2019: First data from the TESEO prospective registry

    European Journal of Internal Medicine, Vol. 78, pp. 41-49

  2. SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)

    Clinical and Translational Oncology, Vol. 22, Núm. 2, pp. 171-186

  3. TESEO, cancer-associated thrombosis registry from the Spanish Society of Medical Oncology (SEOM)

    Clinical and Translational Oncology

2015

  1. Mammographic density and breast cancer in women from high risk families

    Breast Cancer Research, Vol. 17, Núm. 1

2012

  1. Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO)

    Anti-Cancer Drugs, Vol. 23, Núm. 6, pp. 659-665

2009

  1. Spanish society of medical oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients

    Clinical and Translational Oncology, Vol. 11, Núm. 7, pp. 446-454